Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug discovery that is both first-in-class and best-in-class.
The post Trans-Atlantic Triumph: AI Drug Pioneers Recursion, Exscientia Combine appeared first on GEN…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Rep. Frank Pallone (D-NJ) is calling on House Republicans to reauthorize the Pandemic and All-Hazards Preparedness Act in a bid to address the near-record drug shortages in the US. Pallone, a House Energy and Commerce […]
The Program has enabled 25K+ providers to quickly restore operations and accelerate cashflow amid the cyberattack fallout. LEHI, Utah and LOUISVILLE, Ky., April 1, 2024 /PRNewswire/ — Waystar Technologies, Inc., a provider of leading healthcare […]
PARK CITY, Utah, Jan. 31, 2025 /PRNewswire/ — RCBC BidCo Pty Ltd (“BidCo”) today announced the extension of its offer dated November 29, 2024 to acquire up to 100% of the ordinary shares of Parnell […]
Copyright © 2026 Biotech Networks
